The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 1, 2023 | Koziel Margaret | Chief Medical Officer | Sell(S) | 679 | $0.58 | $394 |
| Feb 17, 2023 | Fehlner Paul | SVP & Chief Legal Officer | Grant(A) | 70K | — | $0 |
| Feb 17, 2023 | Hinshaw William | President & CEO, Director | Grant(A) | 275K | — | $0 |
| Feb 17, 2023 | Koziel Margaret | Chief Medical Officer | Grant(A) | 70K | — | $0 |
| Feb 10, 2023 | Fehlner Paul | SVP & Chief Legal Officer | Buy(S) | 5K | $0.66 | $3K |
| Nov 16, 2022 | Rosiello Robert L. | Director | Grant(A) | 40K | — | $0 |
| Nov 16, 2022 | Nissen Torben Straight | Director | Grant(A) | 40K | — | $0 |
| Oct 19, 2022 | Hinshaw William | President & CEO, Director | Sell(S) | 16K | $1.56 | $25K |
| Oct 17, 2022 | Hinshaw William | President & CEO, Director | Grant(A) | 50K | — | — |
| Oct 13, 2022 | Societe des Produits Nestle S.A. | 10% Owner | Buy(P) | 3.7M | $1.64 | $6.0M |
| Oct 13, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 3.0M | $1.64 | $5.0M |
| Oct 13, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 919K | $1.64 | $1.5M |
| Oct 13, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 2.8M | $1.64 | $4.5M |
| Oct 13, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 2.7M | $1.64 | $4.5M |
| Oct 13, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 915K | $1.64 | $1.5M |
| Sep 6, 2022 | Koziel Margaret | Chief Medical Officer | Sell(S) | 547 | $2.52 | $1K |
| Jun 1, 2022 | Koziel Margaret | Chief Medical Officer | Sell(S) | 590 | $2.01 | $1K |
| May 19, 2022 | Rosenblatt Michael | Director | Grant(A) | 40K | — | $0 |
| May 19, 2022 | Pisano Gary P. | Director | Grant(A) | 20K | — | $0 |
| May 19, 2022 | Rondinone CRISTINA | Director | Grant(A) | 20K | — | $0 |
| May 19, 2022 | Baird William D III | Director | Grant(A) | 20K | — | $0 |
| May 19, 2022 | Sohn Catherine A. | Director | Grant(A) | 20K | — | $0 |
| May 19, 2022 | Hendrix Martin | Director | Grant(A) | 40K | — | $0 |
| May 19, 2022 | Sekhri Paul J | Director | Grant(A) | 40K | — | $0 |
| May 19, 2022 | Epstein David R | Director | Grant(A) | 47K | — | $0 |
| Mar 18, 2022 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Mar 18, 2022 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Mar 17, 2022 | Epstein David R | Director | Grant(A) | 50K | — | $0 |
| Mar 16, 2022 | Societe des Produits Nestle S.A. | 10% Owner | Buy(P) | 3.1M | $1.91 | $6.0M |
| Mar 16, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 1.6M | $1.91 | $3.0M |
| Mar 16, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 3.8M | $1.91 | $7.2M |
| Mar 16, 2022 | Flagship Ventures Opportunities Fund I General Partner LLC | 10% Owner | Buy(P) | 948K | $1.91 | $1.8M |
| Mar 16, 2022 | Crane Robert | Chief Financial Officer | Buy(P) | 39K | $1.91 | $75K |
| Mar 16, 2022 | Epstein David R | Director | Buy(P) | 26K | $1.91 | $50K |
| Mar 16, 2022 | Fehlner Paul | SVP & Chief Legal Officer | Buy(P) | 10K | $1.91 | $20K |
| Mar 16, 2022 | Hinshaw William | President & CEO, Director | Buy(P) | 13K | $1.91 | $25K |
| Mar 16, 2022 | Crane Robert | Chief Financial Officer | Grant(A) | 125K | — | $0 |
| Mar 1, 2022 | Koziel Margaret | Chief Medical Officer | Sell(S) | 553 | $1.86 | $1K |
| Feb 18, 2022 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Feb 18, 2022 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Feb 8, 2022 | Dean Virginia R | SVP, Chief People Officer | Grant(A) | 71K | — | $0 |
| Feb 8, 2022 | Koziel Margaret | Chief Medical Officer | Grant(A) | 33K | — | $0 |
| Feb 8, 2022 | Hinshaw William | President & CEO, Director | Grant(A) | 100K | — | $0 |
| Feb 8, 2022 | Hinshaw William | President & CEO, Director | Grant(A) | 275K | — | $0 |
| Feb 8, 2022 | Fehlner Paul | SVP & Chief Legal Officer | Grant(A) | 70K | — | $0 |
| Feb 8, 2022 | Schecter Alison D. | President - Research & Dev. | Grant(A) | 56K | — | $0 |
| Jan 31, 2022 | Hinshaw William | President and CEO, Director | Sell(S) | 17K | $1.65 | $27K |
| Jan 28, 2022 | Hinshaw William | President and CEO, Director | Option exercise(M) | 50K | — | — |
| Jan 28, 2022 | Hinshaw William | President and CEO, Director | Option exercise(M) | 50K | — | $0 |
| Jan 18, 2022 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Jan 18, 2022 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Dec 17, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Dec 17, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Dec 10, 2021 | Koziel Margaret | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Nov 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Nov 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Oct 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Oct 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Sep 17, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Sep 17, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Aug 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Aug 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Aug 13, 2021 | Pisano Gary P. | Director | Option exercise(M) | 81K | — | $0 |
| Aug 13, 2021 | Pisano Gary P. | Director | Option exercise(M) | 81K | $0.28 | $23K |
| Jul 16, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Jul 16, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Jun 22, 2021 | Dean Virginia R | SVP, Chief People Officer | Grant(A) | 140K | — | $0 |
| Jun 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Jun 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| May 20, 2021 | Sohn Catherine A. | Director | Grant(A) | 20K | — | $0 |
| May 20, 2021 | Rondinone CRISTINA | Director | Grant(A) | 20K | — | $0 |
| May 20, 2021 | Pisano Gary P. | Director | Grant(A) | 20K | — | $0 |
| May 20, 2021 | Hoge Stephen | Director | Grant(A) | 20K | — | $0 |
| May 20, 2021 | Behar Gregory | Director | Grant(A) | 20K | — | $0 |
| May 20, 2021 | Baird William D III | Director | Grant(A) | 20K | — | $0 |
| May 20, 2021 | Aradhye Shreeram | Director | Grant(A) | 20K | — | $0 |
| May 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| May 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
| Apr 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | $0 |
| Apr 18, 2021 | Epstein David R | Director | Option exercise(M) | 2K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).